Gilead Sciences (GILD) EBT Margin (2009 - 2026)
Gilead Sciences (GILD) recorded EBT Margin of -131.41% in Q2 2026, down 165.71 percentage points from 34.30% a year earlier and down 168.48 percentage points from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) EBT Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Gilead Sciences' EBT Margin came in at -6.42% as of Jun 30, 2026, down 31.37 percentage points year-over-year; for FY2025, it was 33.27%, up 30.87 percentage points from FY2024.
- Annual EBT Margin has a five-year change of +26.51 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at 2.40% in FY2024 (-22.90 pp), 25.30% in FY2023 (+3.98 pp), 21.31% in FY2022 (-9.01 pp) and 30.32% in FY2021 (+23.56 pp).
- The Q2 2026 figure is the lowest quarterly EBT Margin in data going back to Q1 2009.
- On a year-over-year basis, EBT Margin rose in five of the last eight quarters, with an average year-over-year change of -4.97 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 91.83 percentage points in Q1 2025, against a drop of 165.71 percentage points in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 37.07% (Q1 2026), 26.22% (Q4 2025) and 46.87% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 20.41% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 22.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 36.90% |
| Jun 30, 2026 | -131.41% |
| Mar 31, 2026 | 37.07% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 46.87% |
| Jun 30, 2025 | 34.30% |
| Mar 31, 2025 | 24.73% |
| Dec 31, 2024 | 28.63% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | 29.52% |
| Mar 31, 2024 | -67.10% |
| Dec 31, 2023 | 23.24% |
| Sep 30, 2023 | 32.87% |
| Jun 30, 2023 | 24.06% |
| Mar 31, 2023 | 20.47% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | 34.54% |
| Jun 30, 2022 | 24.01% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 10.48% |
API Access
Gilead Sciences EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();